Interactive Investor
>>

Compugen Ltd (NASDAQ:CGEN) Share Price

CGEN

Compugen Ltd

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

Company Profile

Compugen Ltd is a therapeutic discovery company. It is involved in the business of using its predictive discovery infrastructure to identify novel drug targets and develop biologics. The firm's therapeutic pipeline mainly consists of early-stage immuno-oncology programs aimed at harnessing the immune system to fight cancer. It focuses on immune checkpoint target candidates which are predicted to serve drug targets for cancer immunotherapies addressing various cancer types and also autoimmune diseases.Compugen Ltd is a therapeutic discovery company. The Company's pipeline consists of early-stage immuno-oncology programs aimed at harnessing the immune system to fight cancer.

NASDAQ:CGEN

IL0010852080

USD

Loading...

Loading Comparison

Latest CGEN News